Immune checkpoint blockade toxicity among patients with cancer presenting to the emergency department.

CONCLUSIONS: ICB exposes patients to potentially severe IRAEs. Emergency physicians must identify patients treated with ICB and consider their toxicity when patients present to the ED with symptoms compatible with IRAEs.
PMID: 30910911 [PubMed - as supplied by publisher]

Source: Pain Physician - March 24, 2019 Category: Anesthesiology Authors: Peyrony O, Tieghem Y, Franchitti J, Ellouze S, Morra I, Madelaine-Chambrin I, Flicoteaux R, Baroudjian B, Azoulay E, Chevret S, Fontaine JP Tags: Emerg Med J Source Type: research